HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NU SKIN MUST SUPPORT PRODUCT CLAIMS WITH "COMPETENT AND RELIABLE EVIDENCE,"

This article was originally published in The Rose Sheet

Executive Summary

NU SKIN MUST SUPPORT PRODUCT CLAIMS WITH "COMPETENT AND RELIABLE EVIDENCE," including scientific data "when appropriate," under a proposed consent agreement with the Federal Trade Commission (FTC) announced Jan. 10. The agreement prohibits the multi-level marketing company from "making any representation, directly or by implication, regarding the performance, benefits, efficacy or safety of any product or service...unless at the time of making such representation," the firm or its representatives "possess and rely upon competent and reliable evidence, which when appropriate must be competent and reliable evidence, that substantiates the representation."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000060

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel